Stock VIMAB VIMAB GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Vimab Group AB

Equities

VIMAB

SE0007439633

Market Closed - Nasdaq Stockholm
Other stock markets
 15:35:10 22/05/2024 BST 		5-day change 1st Jan Change
9.08 SEK -1.94% Intraday chart for Vimab Group AB -9.65% +2.48%
05-08 Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-02 Vimab Group AB (OM:VIMAB) has entered into a letter of intent to acquire Elb Kraft Ab for SEK 45 million. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Vimab Group AB (OM:VIMAB) has entered into a letter of intent to acquire Elb Kraft Ab for SEK 45 million.
CI
Vimab Group AB (OM:VIMAB) entered into a letter of intent to acquire Sweden Construction And Services Ab for SEK 35 million.
CI
Vimab Group AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Vimab Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Headsent AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Vimab Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Vimab Group AB (OM:VIMAB) completed the acquisition of B Göransson Produktion Ab for SEK 24.2 million.
CI
Vimab Group AB (OM:VIMAB) signed letter of intent to acquire Solomon Oy for €2.3 million.
CI
Vimab Group AB (OM:VIMAB) enters into letter of intent to acquire Pjp Piping Ab for SEK 12 million.
CI
Vimab Group AB (OM:VIMAB) entered into letter of intent to acquire B Göransson Produktion Ab for SEK 24 million.
CI
Josab Water Solutions AB announced that it expects to receive SEK 42.585 million in funding from Vimab Group AB
CI
Vimab Group AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
Vimab Group AB (OM:VIMAB) signed a letter of intent to acquire 100% stake in Aoo Cnc Ab for SEK 23.3 million.
CI
Headsent AB will Change its Name to Vimab Group AB
CI
Vimab Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Vimab Holding Ab completed the acquisition of Headsent AB (OM:VIMAB) in a reverse merger
CI
Vimab Holding Ab entered into a conditional share transfer agreement to acquire Headsent AB (OM:VIMAB) in a reverse merger for approximately SEK 150 million.
CI
Headsent AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Headsent AB Reports Earnings Results for the Full Year Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIMAB Stock
  4. News Vimab Group AB